Steroid-induced cardiomyopathy

Grants

Funding Acknowledgements

David Hare is a member of advisory boards for Amgen, AstraZeneca, MSD, Novartis, Sanofi, Abbott, CSL Biotherapies and Menarini. He has also previously received research grants or consulting fees from Biotronic, Amgen, Menarini, MSD, Servier, CSL Biotherapies and AstraZeneca, and has received reimbursements for travel expenses from Servier, CSL Biotherapies, Novartis and MSD.